Pharmaceutical company AstraZeneca has paused the trial of its highly-anticipated Covid-19 vaccine. That’s after one participant reportedly had a serious adverse reaction. The vaccine is being developed in collaboration with the University of Oxford. AstraZeneca says it is reviewing safety data. Shamim Chowdhury has the story.
AstraZeneca suspends Covid-19 vaccine trial over safety concern
